Sankala Group’s Thermo Fisher Scientific TMO Stock Holding History

Sankala Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.5K	Hold	82	–	–	0.03%	256
2026 Q1	$39.2K	Hold	82	–	–	0.03%	254
2025 Q4	$42.7K	Buy	+82	New	+$46.4K	0.03%	246

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sankala Group's TMO Position: Q2 2026 in Review

Sankala Group held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 82 shares worth $48.5K. The position accounts for 0.03% of the portfolio, ranked #256.

Sankala Group first reported a position in TMO in Q4 2025 and has held it in 3 quarters since. 2,629 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Sankala Group held 82 shares of Thermo Fisher Scientific worth $48.5K as of Q2 2026.
Sankala Group left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 0.03% of Sankala Group's portfolio in Q2 2026, its #256 holding.
Sankala Group first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 3 quarters since.
2,629 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Sankala Group's 13F filing for Q2 2026, filed 18 Aug 2026.